Zenas BioPharma, Inc. (ZBIO) stock
ZBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
$27.75−0.18 (-0.64%)
Close on Nov 17, 2026Market cap $1.81BP/E –Yield –
Zenas BioPharma cash
Cash and short-term investments held at the end of each period.
Zenas BioPharma's cash was $647.10M at Sep 30, 2026. For fiscal 2025 it was $360.50M, up 2.8% from the year before.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $360.50M | +2.8% |
| FY2024 | Dec 31, 2024 | $350.80M | +516.1% |
| FY2023 | Dec 31, 2023 | $56.94M | -15.4% |
| FY2022 | Dec 31, 2022 | $67.30M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $647.10M | +114.6% |
| Q2 FY2026 | Jun 30, 2026 | $673.90M | +145.1% |
| Q1 FY2026 | Mar 31, 2026 | $718.50M | +128.7% |
| Q4 FY2025 | Dec 31, 2025 | $360.50M | +2.8% |
| Q3 FY2025 | Sep 30, 2025 | $301.60M | -22.0% |
| Q2 FY2025 | Jun 30, 2025 | $274.90M | +49.5% |
| Q1 FY2025 | Mar 31, 2025 | $314.20M | +745.7% |
| Q4 FY2024 | Dec 31, 2024 | $350.80M | +516.1% |
| Q3 FY2024 | Sep 30, 2024 | $386.80M | +434.9% |
| Q2 FY2024 | Jun 30, 2024 | $183.93M | +173.3% |
| Q1 FY2024 | Mar 31, 2024 | $37.15M | – |
| Q4 FY2023 | Dec 31, 2023 | $56.94M | – |
| Q3 FY2023 | Sep 30, 2023 | $72.31M | – |
| Q4 FY2022 | Dec 31, 2022 | $67.30M | – |
See a number that looks wrong?